ALS is a heterogeneous disease. While 10-15% of cases are linked to inherited mutations, nearly 85% are sporadic.
A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for ...
Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene therapy ...
X-Cell generalizes to new biological contexts and breaks barriers as the first scaling law demonstrator in the virtual cell domain.
iXCells’ mission is to empower life science researchers and patient foundations to advance personalized therapies and accelerate discovery of better medicines for a healthier future. iXCells’ cell ...
PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving ...
Hosted on MSN
Exciting advancement in 3D embryo models shows lab-grown cells making their own blood supply
Creating human structures in a lab is always difficult, but when successful, it can open up a lot of possibilities. Recently, researchers have been working on using 3D embryo structures called ...
In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results